Evidence map›Paper›PMID 28211008›Full record

ArticleMolecular neurobiology2018

Injected Amyloid Beta in the Olfactory Bulb Transfers to Other Brain Regions via Neural Connections in Mice.

Baixuan He, Minying Zheng, Qiang Liu, Zhe Shi, Simei Long, Xilin Lu, Zhong Pei, Ti-Fei Yuan, Huanxing Su, Xiaoli Yao

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Prion-like properties of disease-relevant proteins in amyotrophic lateral sclerosis.Journal of neural transmission (Vienna, Austria : 1996) · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Baixuan HeDepartment of Neurology, National Key Clinical Department and Key Discipline of Neurology, and Guangdong Provincial Key Laboratory for Diagnosis and Treatment of Major Neurological Diseases, The First Affiliated Hospital Sun Yat-Sen University, Guangzhou, 510080, China.
Minying ZhengDepartment of Neurology, National Key Clinical Department and Key Discipline of Neurology, and Guangdong Provincial Key Laboratory for Diagnosis and Treatment of Major Neurological Diseases, The First Affiliated Hospital Sun Yat-Sen University, Guangzhou, 510080, China.
Qiang LiuState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, 999078, China.
Zhe ShiState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, 999078, China.
Simei LongDepartment of Neurology, National Key Clinical Department and Key Discipline of Neurology, and Guangdong Provincial Key Laboratory for Diagnosis and Treatment of Major Neurological Diseases, The First Affiliated Hospital Sun Yat-Sen University, Guangzhou, 510080, China.
Xilin LuDepartment of Neurology, National Key Clinical Department and Key Discipline of Neurology, and Guangdong Provincial Key Laboratory for Diagnosis and Treatment of Major Neurological Diseases, The First Affiliated Hospital Sun Yat-Sen University, Guangzhou, 510080, China.
Zhong PeiDepartment of Neurology, National Key Clinical Department and Key Discipline of Neurology, and Guangdong Provincial Key Laboratory for Diagnosis and Treatment of Major Neurological Diseases, The First Affiliated Hospital Sun Yat-Sen University, Guangzhou, 510080, China.
Ti-Fei YuanSchool of Psychology, Nanjing Normal University, Nanjing, China.
Huanxing SuState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, 999078, China. huanxingsu@umac.mo.
Xiaoli YaoDepartment of Neurology, National Key Clinical Department and Key Discipline of Neurology, and Guangdong Provincial Key Laboratory for Diagnosis and Treatment of Major Neurological Diseases, The First Affiliated Hospital Sun Yat-Sen University, Guangzhou, 510080, China. liliyao71@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease (AD) is characterized by progressive neuronal degeneration and pathological accumulation of amyloid plaques in the brain. It has been proposed that the prion-like spreading of amyloid beta (Aβ) protein could contribute to the progression of the disease. Olfactory bulb (OB) is one of the earliest brain regions affected in AD and olfaction is easily impaired prior to cognitive symptoms. However, it remains unclear whether Aβ accumulation in the OB would spread along olfactory projections to other connected brain regions and trigger further neurodegeneration. In the present study, we experimentally injected recombinant human Aβ1-42 (monomers and oligomers, respectively) into the mouse OB and tracked the spreading of Aβ to connected brain regions over 3 days. The results showed that both Aβ monomers and oligomers were rapidly and readily transferred from the injection site to interconnected brain regions in a neural connection manner and triggered neuronal apoptosis in the affected brain regions. Oligomeric Aβ1-42 spread more efficiently and induced more neuronal apoptosis in the affected brain regions compared to monomeric Aβ1-42. Therefore, the study provides evidence that Aβ peptides can transfer via neural connections and the pattern of Aβ peptide spreading provides understanding to manage AD.

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesAnimalsApoptosisBrainMaleMiceMice, Inbred C57BLNerve DegenerationNeural PathwaysOlfactory BulbAmyloid beta-PeptidesAlzheimer’s diseaseApoptosisNeural connectionsOlfactory pathwayOligomers

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.